메뉴 건너뛰기
Neurology
Volumn 78, Issue 22, 2012, Pages
Journal club: Intrathecal effects of daclizumab treatment of multiple sclerosis
Author keywords

[No Author keywords available]
Indexed keywords

DACLIZUMAB;
EID: 84863608009     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31825830e3     Document Type: Article
Times cited : (1)
References (10)
  • 1
    • 82955225356 scopus 로고    scopus 로고
    • Intrathecal effects of daclizumab treatment of multiple sclerosis
    • Bielekova B, Richert N, Herman ML, et al. Intrathecal effects of daclizumab treatment of multiple sclerosis. Neurology 2011;77:1877-1886.
    • (2011) Neurology , vol.77 , pp. 1877-1886
    • Bielekova, B.1    Richert, N.2    Herman, M.L.3
  • 2
    • 17644396349 scopus 로고    scopus 로고
    • Immunology of multiple sclerosis
    • DOI 10.1146/annurev.immunol.23.021704.115707
    • Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747. (Pubitemid 40563183)
    • (2005) Annual Review of Immunology , vol.23 , pp. 683-747
    • Sospedra, M.1    Martin, R.2
  • 3
    • 80054774245 scopus 로고    scopus 로고
    • B cellderived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients
    • Schneider R, Mohebiany AN, Ifergan I, et al. B cellderived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients. J Immunol 2011; 187:4119-4128.
    • (2011) J Immunol , vol.187 , pp. 4119-4128
    • Schneider, R.1    Mohebiany, A.N.2    Ifergan, I.3
  • 4
    • 79955700857 scopus 로고    scopus 로고
    • A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy
    • Wuest SC, Edwan JH, Martin JF, et al. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med 2011;17:604-609.
    • (2011) Nat Med , vol.17 , pp. 604-609
    • Wuest, S.C.1    Edwan, J.H.2    Martin, J.F.3
  • 5
    • 33645812129 scopus 로고    scopus 로고
    • Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis
    • Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 2006;103:5941-5946.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 5941-5946
    • Bielekova, B.1    Catalfamo, M.2    Reichert-Scrivner, S.3
  • 6
    • 65249138318 scopus 로고    scopus 로고
    • Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis
    • Bielekova B, Howard T, Packer AN, et al. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol 2009;66:483-489.
    • (2009) Arch Neurol , vol.66 , pp. 483-489
    • Bielekova, B.1    Howard, T.2    Packer, A.N.3
  • 7
    • 77949301468 scopus 로고    scopus 로고
    • Daclizumab in active relapsing multiple sclerosis (CHOICE study): A phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
    • Wynn D, Kaufman M, Montalban X, et al. Daclizumab in active relapsing multiple sclerosis (CHOICE study): A phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurol 2010;9: 381-390.
    • (2010) Lancet Neurol , vol.9 , pp. 381-390
    • Wynn, D.1    Kaufman, M.2    Montalban, X.3
  • 8
    • 79960344014 scopus 로고    scopus 로고
    • Natalizumab treatment for multiple sclerosis: Updated recommendations for patient selection and monitoring
    • Kappos L, Bates D, Edan G, et al. Natalizumab treatment for multiple sclerosis: Updated recommendations for patient selection and monitoring. Lancet Neurol 2011;10: 745-758.
    • (2011) Lancet Neurol , vol.10 , pp. 745-758
    • Kappos, L.1    Bates, D.2    Edan, G.3
  • 9
    • 79952501096 scopus 로고    scopus 로고
    • Diagnostic criteria for multiple sclerosis: 2010 revisions to the Mc-Donald criteria
    • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the Mc-Donald criteria. Ann Neurol 2011;69:292-302.
    • (2011) Ann Neurol , vol.69 , pp. 292-302
    • Polman, C.H.1    Reingold, S.C.2    Banwell, B.3
  • 10
    • 77953850655 scopus 로고    scopus 로고
    • T cells with commitment issues
    • Schneider R. T cells with commitment issues. Sci Signal 2010;3:jc3.
    • (2010) Sci Signal , vol.3
    • Schneider, R.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.